Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T23:12:01.007Z Has data issue: false hasContentIssue false
  • English
  • Français

Gender differences in panic disorder symptoms and illicit drug use among young people in Hungary

Published online by Cambridge University Press:  16 April 2020

I. Kecskés ,
Z. Rihmer ,
K. Kiss ,
T. Sárai ,
A. Szabó  and
G.H. Kiss
I. Kecskés
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
Z. Rihmer*
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
K. Kiss
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
T. Sárai
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
A. Szabó
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
G.H. Kiss
Affiliation:
In- and Outpatient Department of Psychiatry No. XIII, National Institute for Psychiatry and Neurology, Budapest 27., POB 1, 1281, Hungary
*
*Correspondence and reprints: 1021, Budapest, Hűvösvölgyi u 116, Hungary.
Get access

Summary

The authors have investigated the frequency of illicit drug use, and spontaneous and drug-provoked panic disorder symptoms in Hungarian youths. A semi-structured self-reporting questionnaire (with questions about drug usage and the persistence of some DSM-IV panic disorder symptoms) was filled out in discos/nightclubs, secondary schools and universities. Almost 17% of the total sample (n = 1298) reported on illicit drug-use at least once in their life, and this rate was significantly higher among males. Regardless of the illegal drug use 14.6% of the total sample reported on four or more DSM-IV symptoms of panic disorder, and this rate was significantly higher among females. Analyzing the panic disorder symptoms only among drug-users (n = 219), the frequency of persons with four or more anxiety symptoms was 14.1% before drug use, and it increased to 30.6% during the period of drug use (P < 0.001). The findings support previous results showing (i) higher prevalence of anxiety symptoms among females; (ii) higher rate of illicit drug use among males; and (iii) a possible anxiety-provoking effect of illicit drugs.

Keywords

drug usegender differencespanic disorder symptoms
Type
Short communication
Information
European Psychiatry , Volume 17 , Issue 1 , March 2002 , pp. 29 - 32
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS. 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: APA; 1994.Google Scholar
Bácskai, EKábítószerek használata az ifjúsági populációban. In: Németh, AGerevich, J Eds. Addikciók. Budapest: Medicina; 2000. p. 31–51.Google Scholar
Creighton, FJBlack, DLHyde, CE‘Ecstasy’ psychosis and flashbacks. Br J Psychiatry 1991; 159; 713–5.CrossRefGoogle Scholar
Eaton, WWKessler, RCWittchen, HUMagee, WJPanic and panic disorder in United States. Am J Psychiatry 1994; 151; 413–210.Google ScholarPubMed
Kessler, RCMcGonagle, KAZhao, SNelson, CBHughes, MEshelman, Set al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51; 8–19.CrossRefGoogle ScholarPubMed
Madianos, MGGefou-Madianou, DRichardson, CStefanis, CNFactors affecting illicit and licit drug use among adolescents and young adults in Greece. Acta Psychiatr Scand 1995; 91; 258–64.CrossRefGoogle Scholar
Pallanti, SMazzi, DMDMA (Ecstasy) precipitation of panic disorder. Biol Psychiatry 1992; 32; 91–5.CrossRefGoogle ScholarPubMed
Pélissolo, ALépine, YPEpidemiology of depression and anxiety disorders. In: Montgomery, SAden Boer, JA Eds. SSRIs in depression and anxiety. Chichester: John Wiley and Sons; 1997. p. 1–21.Google Scholar
Pini, SPerkonnig, ATansella, MWittchen, HUPrevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care. J Affect Disord 1999; 56; 37–48.CrossRefGoogle ScholarPubMed
Szádóczky, EPapp, ZSVitrai, JFüredi, JA hangulat- és szorongásos zavarok előfordulása a felnőtt magyar lakosság körében. (The prevalence of mood and anxiety disorders in the adult population of Hungary. Orvosi Hetilap 2000; 141; 17–22.Google Scholar
Tunving, KPsychiatric effects of cannabis use. Acta Psychiatr Scand 1985; 72; 209–17.CrossRefGoogle ScholarPubMed
Veér, ANádori, GErőss, LAlternatív drogstratégia. Budapest: Animula; 2000. p. 61.Google Scholar
Verheul, RKranzler, HRPoling, JTennen, HBall, SRounsaville, BJCo-occurrence of Axis I and Axis II disorders in substance abusers. Acta Psychiatr Scand 2000; 101; 110–8.CrossRefGoogle ScholarPubMed
Williamson, SGossop, MPowis, BGriffiths, PFountain, JStrang, JAdverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 1997; 44; 2–3.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.